Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc. (MHTX) Revenue
Annual & quarterly revenue history · segment & region breakdown
MHTX · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsManhattan Scientifics, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 100.00% year-over-year from $0.00B in FY2023.
Revenue trend
2023 – 2004 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2023-12-31 | $0.00B | -$0.00B | -100.00% |
| 2022-12-31 | $0.00B | +$0.00B | +0.00% |
| 2021-12-31 | $0.00B | +$0.00B | +0.00% |
| 2020-12-31 | $0.00B | -$0.00B | -48.45% |
| 2019-12-31 | $0.00B | +$0.00B | — |
| 2018-12-31 | $0.00B | -$0.00B | -100.00% |
| 2017-12-31 | $0.00B | -$0.00B | -5.33% |
| 2016-12-31 | $0.00B | +$0.00B | +134.38% |
| 2015-12-31 | $0.00B | -$0.00B | -90.03% |
| 2014-12-31 | $0.00B | -$0.00B | -1.53% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Manhattan Scientifics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Manhattan Scientifics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Manhattan Scientifics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MHTX revenue · 4 questionsMHTX's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 100.00% year-over-year from $0.00B in FY2023.
▸ Source: FMP · Manhattan Scientifics, Inc. SEC filings · GAAP · Manhattan Scientifics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026